Free Trial
ASX:EZZ

EZZ Life Science (EZZ) Stock Price, News & Analysis

About EZZ Life Science Stock (ASX:EZZ)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$87.74 million
P/E Ratio
11.61
Dividend Yield
1.88%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EZZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EZZ Life Science and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EZZ Stock News Headlines

Alert: Prepare for Trump's Dollar Overhaul
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."tc pixel
See More Headlines

EZZ Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that EZZ Life Science investors own include Allied Gaming & Entertainment (AGAE), AGL Energy (AGL), AMP (AMP), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY) and Global X Cloud Computing ETF (CLOU).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:EZZ
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.08
Trailing P/E Ratio
11.61
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
A$6.96 million
Net Margins
10.48%
Pretax Margin
N/A
Return on Equity
38.04%
Return on Assets
28.12%

Debt

Debt-to-Equity Ratio
0.58
Current Ratio
5.96
Quick Ratio
4.53

Sales & Book Value

Annual Sales
A$66.44 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.49 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
44,420,000
Free Float
N/A
Market Cap
A$87.74 million
Optionable
Not Optionable
Beta
0.47
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (ASX:EZZ) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners